Table 3.

Disease-specific survival rates based on MCT1 and MCT4 stainings (intensity, percentage, MCT score, and stromal staining) in both primary tumors and lymph node metastases. Lymph node metastases showed negative MCT1 staining and therefore these are not presented.

Disease-Specific Survival	No. of Patients	MCT1 Intensity, Low	MCT1 Intensity, High		p
Primary tumors	109	66.7%	64.0%		0.825
	No. of patients	MCT1 percentage, low	MCT1 percentage, high		p
Primary tumors	109	51.8%	68.0%		0.841
	No. of patients	MCT1 score 0	MCT1 score 1	MCT1 score 2	p
Primary tumors	109	54.4%	72.9%	64.3%	0.999
	No. of patients	MCT4 intensity, low	MCT4 intensity, high		p
Primary tumors	104	56.6%	85.7%		0.020
Lymph node metastases	61	62.6%	73.6%		0.345
	No. of patients	MCT4 percentage, low	MCT4 percentage, high		p
Primary tumors	104	49.1%	77.4%		0.058
Lymph node metastases	61	71.1%	65.1%		0.856
	No. of patients	MCT4 stroma, negative	MCT4 stroma, positive		p
Primary tumors	104	65.7%	51.9%		0.469
Lymph node metastases	61	65.7%	75.6%		0.659
	No. of patients	MCT4 score 0	MCT4 score 1	MCT4 score 2	p
Primary tumors	104	52.8%	58.8%	100%	0.025
Lymph node metastases	61	70.0%	56.5%	73.4%	0.678